News Focus
News Focus
Replies to #79545 on Biotech Values
icon url

genisi

06/15/09 4:59 AM

#79551 RE: DewDiligence #79545

I bet you'd like the Hebrew version better, the headline is less soft and says (my more objective translation):
"Former Barr Chief prefers Teva's Rival: Joins Board at Momenta, that developed generic Copaxone version"
And in the text, Gabison calls Downey's statements following his appointment - "embarrassing for Teva". The sting (very likely on purpose), was lost in translation.
icon url

apljack

06/15/09 6:38 PM

#79577 RE: DewDiligence #79545

"Former Barr Chief Joins Board at Teva Rival Momenta"

Dew, I follow what you posts about MNTA with great interest. I don't recall the press characterizing MNTA as a rival to TEVA before. Is this a new characterization?

aj